Search

Author/Creator Caccese, Mario

1. A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib. Issue 2 (14th July 2020)

Authors:
Santangelo, Alessandra; Rossato, Marzia; Lombardi, Giuseppe; Benfatto, Salvatore; Lavezzari, Denise; De Salvo, Gian Luca; Indraccolo, Stefano; Dechecchi, Maria Cristina; Prandini, Paola; Gambari, Roberto; Scapoli, Chiara; Di Gennaro, Gianfranco; Caccese, Mario; Eoli, Marica; Rudà, Roberta; Brande...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 2(2021)
Page Start:
264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer. (September 2015)

Authors:
Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio
Journal:
Expert opinion on investigational drugs
Issue:
Volume 24:Number 9(2015:Sep.)
Page Start:
1143
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anaplastic Astrocytoma: State of the art and future directions. (September 2020)

Authors:
Caccese, Mario; Padovan, Marta; D'Avella, Domenico; Chioffi, Franco; Gardiman, Marina Paola; Berti, Franco; Busato, Fabio; Bellu, Luisa; Bergo, Eleonora; Zoccarato, Marco; Fassan, Matteo; Zagonel, Vittorina; Lombardi, Giuseppe
Journal:
Critical reviews in oncology/hematology
Issue:
Volume 153(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Antigen rapid diagnostic test monitoring for SARS‐CoV‐2 in asymptomatic and fully vaccinated cancer patients: Is it cost‐effective?. (30th December 2022)

Authors:
Caccese, Mario; Saieva, Anna Maria; Guarneri, Valentina; Lonardi, Sara; Cacco, Massimo; Sileni, Vanna Chiarion; Gottardi, Michele; Mioranza, Eleonora; Bergamo, Francesca; Brunello, Antonella; Zagonel, Vittorina; Benini, Patrizia
Journal:
Cancer medicine
Issue:
Volume 12:Number 7(2023)
Page Start:
7795
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. BIOM-19. NEXT-GENERATION SEQUENCING (NGS) FOR IDENTIFYING ACTIONABLE MOLECULAR ALTERATIONS IN NEWLY DIAGNOSED AND RECURRENT IDHWT-GLIOBLASTOMA (GBM) PATIENTS: A LARGE MONO INSTITUTIONAL EXPERIENCE. (14th November 2022)

Authors:
Padovan, Marta; Maccari, Marta; Bosio, Alberto; Vizzaccaro, Salvatore; Cestonaro, Ilaria; Corrà, Martina; Caccese, Mario; Cerretti, Giulia; Fassan, Matteo; Zagonel, Vittorina; Lombardi, Giuseppe
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. BIOM-21. THE SIGNIFICANCE OF TERT PROMOTER MUTATIONS, TELOMERE LENGTH AND MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED AND RECURRENT IDH-WILDTYPE GLIOBLASTOMA (GBM): A LARGE MONO-INSTITUTIONAL STUDY. (12th November 2021)

Authors:
Lombardi, Giuseppe; Giunco, Silvia; Cavallin, Francesco; Angelini, Chiara; Caccese, Mario; Cerretti, Giulia; De Bonis, Pasquale; De Rossi, Anita; Zagonel, Vittorina
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study. (May 2020)

Authors:
Parrozzani, Raffaele; Lombardi, Giuseppe; Midena, Edoardo; Leonardi, Francesca; Londei, Davide; Padovan, Marta; Caccese, Mario; Marchione, Giulia; Bini, Silvia; Zagonel, Vittorina; Frizziero, Luisa
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 12(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL. (14th November 2022)

Authors:
Pace, Andrea; Lombardi, Giuseppe; Matteoni, Silvia; Villani, Veronica; Benincasa, Dario; Abruzzese, Claudia; Cerretti, Giulia; Caccese, Mario; Silvani, Antonio; Paggi, Marco Giorgio
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii72
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS SYNERGISM WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL. (12th November 2021)

Authors:
Pace, Andrea; Lombardi, Giuseppe; Matteoni, Silvia; Villani, Veronica; Abruzzese, Caludia; Cerretti, Giulia; Padovan, Marta; Caccese, Mario; Benincasa, Dario; Silvani, Antonio; Paggi, Marco
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi61
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗